Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:16am, Thursday, 30'th Oct 2025
Get a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for som
AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS
04:01pm, Wednesday, 29'th Oct 2025
THOUSAND OAKS, Calif. , Oct. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2025 financial results on Tuesday, November 4, 2025, after the close o
Amgen's Q3 Earnings in the Cards: Here's What to Expect
12:31pm, Wednesday, 29'th Oct 2025
Amgen's Q3 results are on deck, with growth from newer drugs offset by biosimilar competition and pricing pressures.
Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline
11:01am, Tuesday, 28'th Oct 2025
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights
07:22pm, Wednesday, 22'nd Oct 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amgen Inc. (NASDAQ: AMGN) breached their fiduciary duties to shareh
Why Amgen (AMGN) Dipped More Than Broader Market Today
07:01pm, Wednesday, 22'nd Oct 2025
The latest trading day saw Amgen (AMGN) settling at $295.98, representing a -1.71% change from its previous close.
5 Best Dividend Stocks in the Nasdaq Composite
01:37pm, Monday, 20'th Oct 2025
What's the first thing that springs to mind when someone mentions the Nasdaq Composite?
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:01am, Monday, 20'th Oct 2025
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
US FDA expands use of Amgen, AstraZeneca's drug for sinus infection
04:08pm, Friday, 17'th Oct 2025
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic sinus infection, the drugmakers said on Friday.
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
04:00pm, Friday, 17'th Oct 2025
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif. , Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca
Amgen (AMGN) Laps the Stock Market: Here's Why
06:51pm, Wednesday, 15'th Oct 2025
In the closing of the recent trading day, Amgen (AMGN) stood at $297.32, denoting a +1.18% move from the preceding trading day.
Why Amgen (AMGN) Could Beat Earnings Estimates Again
01:11pm, Monday, 13'th Oct 2025
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
10:01am, Wednesday, 08'th Oct 2025
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
03:31pm, Tuesday, 07'th Oct 2025
Amgen is the latest drugmaker to sell certain drugs directly to consumers amid pressure from President Donald Trump. Meanwhile, Dr. Oz talks GLP-1s for obesity.
Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%
02:46pm, Tuesday, 07'th Oct 2025
AMGN rolls out AmgenNow, a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.
